Login
Home
Charts
Search
Watchlist
Products

Gujarat Fluorochemicals Ltd

FLUOROCHEM·NSE
4,487.20-1.60%Tue, 22 Sept '26

Gujarat Fluorochemicals Ltd

FLUOROCHEM
NSE
4,487.20
-1.60%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
49,262Cr
Close
Close Price
4,484.50
Industry
Industry
Chemicals - Flourine
PE
Price To Earnings
80.53
PS
Price To Sales
9.29
Revenue
Revenue
5,303Cr
Rev Gr TTM
Revenue Growth TTM
9.52%
PAT Gr TTM
PAT Growth TTM
-3.23%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
9479921,1331,1761,1881,1481,2251,2811,2101,1361,3691,588
Growth YoY
Revenue Growth YoY%
-35.2-30.0-23.0-2.725.415.78.18.91.9-1.111.824.0
Expenses
ExpensesCr
7837868959148938549199378468611,0611,160
Operating Profit
Operating ProfitCr
164206238262295294306344364275308428
OPM
OPM%
17.320.821.022.324.825.625.026.930.124.222.526.9
Other Income
Other IncomeCr
131318991426236-10210
Interest Expense
Interest ExpenseCr
343734374242263033334226
Depreciation
DepreciationCr
6872818590918990918997102
PBT
PBTCr
75110141149172175217247246143171310
Tax
TaxCr
223040415149266567417191
PAT
PATCr
5380101108121126191182179102100219
Growth YoY
PAT Growth YoY%
-85.2-75.8-69.6-46.3128.357.589.168.547.9-19.1-47.620.3
NPM
NPM%
5.68.18.99.210.211.015.614.214.89.07.313.8
EPS
EPS
4.87.39.29.811.011.517.416.816.39.39.920.2
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
9479921,1331,1761,1881,1481,2251,2811,2101,1361,3691,588
Growth YoY
Revenue Growth YoY%
-35.2-30.0-23.0-2.725.415.78.18.91.9-1.111.824.0
Expenses
ExpensesCr
7837868959148938549199378468611,0611,160
Operating Profit
Operating ProfitCr
164206238262295294306344364275308428
OPM
OPM%
17.320.821.022.324.825.625.026.930.124.222.526.9
Other Income
Other IncomeCr
131318991426236-10210
Interest Expense
Interest ExpenseCr
343734374242263033334226
Depreciation
DepreciationCr
6872818590918990918997102
PBT
PBTCr
75110141149172175217247246143171310
Tax
TaxCr
223040415149266567417191
PAT
PATCr
5380101108121126191182179102100219
Growth YoY
PAT Growth YoY%
-85.2-75.8-69.6-46.3128.357.589.168.547.9-19.1-47.620.3
NPM
NPM%
5.68.18.99.210.211.015.614.214.89.07.313.8
EPS
EPS
4.87.39.29.811.011.517.416.816.39.39.920.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,8512,7292,6062,6513,9545,6854,2814,7374,9965,303
Growth
Revenue Growth%
-29.1-4.51.749.243.8-24.710.75.59.5
Expenses
ExpensesCr
3,2981,9412,1672,0552,7853,7193,3733,6393,7943,928
Operating Profit
Operating ProfitCr
5537884395961,1681,9659071,0991,2021,375
OPM
OPM%
14.328.916.922.529.634.621.223.224.125.9
Other Income
Other IncomeCr
123781902011611721071161108
Interest Expense
Interest ExpenseCr
2795610511378117133147138134
Depreciation
DepreciationCr
299164192202205236286355367379
PBT
PBTCr
2796453324821,0451,785595713807870
Tax
TaxCr
39-601143704269462160167233270
PAT
PATCr
2401,246189-2227761,323435546574600
Growth
PAT Growth%
419.1-84.8-217.0450.270.5-67.125.55.1-3.2
NPM
NPM%
6.245.77.3-8.419.623.310.211.511.511.3
EPS
EPS
21.9113.717.2-20.270.6120.439.649.752.355.7
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,8512,7292,6062,6513,9545,6854,2814,7374,9965,303
Growth
Revenue Growth%
-29.1-4.51.749.243.8-24.710.75.59.5
Expenses
ExpensesCr
3,2981,9412,1672,0552,7853,7193,3733,6393,7943,928
Operating Profit
Operating ProfitCr
5537884395961,1681,9659071,0991,2021,375
OPM
OPM%
14.328.916.922.529.634.621.223.224.125.9
Other Income
Other IncomeCr
123781902011611721071161108
Interest Expense
Interest ExpenseCr
2795610511378117133147138134
Depreciation
DepreciationCr
299164192202205236286355367379
PBT
PBTCr
2796453324821,0451,785595713807870
Tax
TaxCr
39-601143704269462160167233270
PAT
PATCr
2401,246189-2227761,323435546574600
Growth
PAT Growth%
419.1-84.8-217.0450.270.5-67.125.55.1-3.2
NPM
NPM%
6.245.77.3-8.419.623.310.211.511.511.3
EPS
EPS
21.9113.717.2-20.270.6120.439.649.752.355.7

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
111111111111111111
Reserves
ReservesCr
4,7563,4993,7053,4824,2445,5105,9257,1927,805
Current Liabilities
Current LiabilitiesCr
2,9811,2051,8431,7891,9062,3392,5032,5232,560
Non Current Liabilities
Non Current LiabilitiesCr
9792075197017415127957871,411
Total Liabilities
Total LiabilitiesCr
9,9204,9196,0675,9696,8788,3719,23410,60811,883
Current Assets
Current AssetsCr
3,9661,4071,9271,9232,4383,4713,4044,2834,408
Non Current Assets
Non Current AssetsCr
5,9543,5114,1404,0454,4404,9005,8316,3257,476
Total Assets
Total AssetsCr
9,9204,9196,0675,9696,8788,3719,23410,60811,883
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
111111111111111111
Reserves
ReservesCr
4,7563,4993,7053,4824,2445,5105,9257,1927,805
Current Liabilities
Current LiabilitiesCr
2,9811,2051,8431,7891,9062,3392,5032,5232,560
Non Current Liabilities
Non Current LiabilitiesCr
9792075197017415127957871,411
Total Liabilities
Total LiabilitiesCr
9,9204,9196,0675,9696,8788,3719,23410,60811,883
Current Assets
Current AssetsCr
3,9661,4071,9271,9232,4383,4713,4044,2834,408
Non Current Assets
Non Current AssetsCr
5,9543,5114,1404,0454,4404,9005,8316,3257,476
Total Assets
Total AssetsCr
9,9204,9196,0675,9696,8788,3719,23410,60811,883

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
952782546616741739626545961
Investing Cash Flow
Investing Cash FlowCr
589-428-1,192-373-584-476-966-1,121-1,168
Financing Cash Flow
Financing Cash FlowCr
-1,668110622-248-144-264348599367
Net Cash Flow
Net Cash FlowCr
-127464-24-514-2724160
Free Cash Flow
Free Cash FlowCr
-62276-6503439269-315-272-246
CFO To PAT
CFO To PAT%
396.562.7288.6-278.395.555.9144.099.9167.4
CFO To EBITDA
CFO To EBITDA%
172.399.2124.5103.463.537.669.049.679.9
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
952782546616741739626545961
Investing Cash Flow
Investing Cash FlowCr
589-428-1,192-373-584-476-966-1,121-1,168
Financing Cash Flow
Financing Cash FlowCr
-1,668110622-248-144-264348599367
Net Cash Flow
Net Cash FlowCr
-127464-24-514-2724160
Free Cash Flow
Free Cash FlowCr
-62276-6503439269-315-272-246
CFO To PAT
CFO To PAT%
396.562.7288.6-278.395.555.9144.099.9167.4
CFO To EBITDA
CFO To EBITDA%
172.399.2124.5103.463.537.669.049.679.9

Ratios

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3,1866,31930,19133,12634,02544,17533,29049,262
Price To Earnings
Price To Earnings
16.238.424.978.380.957.780.5
Price To Sales
Price To Sales
1.22.47.65.88.09.36.79.3
Price To Book
Price To Book
0.91.87.16.05.76.14.36.3
EV To EBITDA
EV To EBITDA
10.712.927.017.539.641.929.738.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
55.546.538.840.745.950.041.443.944.744.7
OPM
OPM%
14.328.916.922.529.634.621.223.224.125.9
NPM
NPM%
6.245.77.3-8.419.623.310.211.511.511.3
ROCE
ROCE%
8.715.98.312.119.327.09.19.39.09.0
ROE
ROE%
5.035.55.1-6.318.224.07.37.67.37.3
ROA
ROA%
2.425.33.1-3.711.315.84.75.24.84.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3,1866,31930,19133,12634,02544,17533,29049,262
Price To Earnings
Price To Earnings
16.238.424.978.380.957.780.5
Price To Sales
Price To Sales
1.22.47.65.88.09.36.79.3
Price To Book
Price To Book
0.91.87.16.05.76.14.36.3
EV To EBITDA
EV To EBITDA
10.712.927.017.539.641.929.738.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
55.546.538.840.745.950.041.443.944.744.7
OPM
OPM%
14.328.916.922.529.634.621.223.224.125.9
NPM
NPM%
6.245.77.3-8.419.623.310.211.511.511.3
ROCE
ROCE%
8.715.98.312.119.327.09.19.39.09.0
ROE
ROE%
5.035.55.1-6.318.224.07.37.67.37.3
ROA
ROA%
2.425.33.1-3.711.315.84.75.24.84.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Gujarat Fluorochemicals Ltd is a company built on a single, difficult-to-master element: fluorine. Incorporated in 1987, it began by making refrigerant gases and has spent nearly four decades climbing the fluorine value chain, transforming from a commodity chemical producer into one of the world’s top four manufacturers of high-performance fluoropolymers and a credible non-Chinese supplier of battery materials for the energy transition. The recurring approach that explains everything else is a relentless drive for vertical integration - controlling the journey from raw fluorspar rock, often from its own mine in Morocco, all the way to advanced materials that go into semiconductors, electric vehicles, and green hydrogen, so that it captures value, secures supply, and controls quality at every step. # Business segments Five engines at different stages - a hydrocarbon cash cow, two consumer platforms at national scale, and a green-energy bet under construction - each built with the cash flows of the one before. ## 1. Fluoropolymers: the advanced-materials core that everything else is built on **These are high-performance plastics with properties so unique - fireproof, non-stick, weatherproof, and electrically insulating - that management says they have no technically viable substitutes, and the company is one of only a handful of players globally who can make them at scale.** - **A family of super-plastics** - the portfolio spans PTFE (the original non-stick material), PFA, PVDF, FEP, fluoroelastomers (FKM), and others, sold under the FLUON brand into over 20 industries including semiconductors, aerospace, automotive, and cookware. - **A moat built on pain, not patents** - the barriers to entry are formidable: the technical know-how, the capital intensity, the dangerous process safety requirements, and a customer validation cycle that is time-consuming and rigorous, which together keep the field of competitors small. - **Moving up the value ladder** - the company is deliberately shifting its mix from commodity-grade PTFE, which faces pricing pressure from Chinese competitors, toward newer, higher-margin products like PFA and FKM that are driven by demand from semiconductor fabs, AI data centers, and advanced automotive applications. - **A beneficiary of global retreat** - as legacy European manufacturers exit the fluoropolymer market, GFL is stepping in as a key, integrated supplier to Europe and the USA, filling a supply gap that has opened in high-end markets. ## 2. Fluorochemicals: the refrigerants and specialty molecules that started it all **This is the diversified chemical engine that produces refrigerant gases and specialty intermediates for agrochemicals and pharmaceuticals, built on the same integrated fluorine platform and now expanding into next-generation, low-emission cooling.** - **Largest R-22 producer from India** - the refrigerant portfolio includes R-22, R-32, R-125, and various HFC and HFO blends, with demand underpinned by rising air-conditioning penetration, cold-chain infrastructure, and the massive cooling needs of AI data centers globally. - **Riding the regulatory wave** - tightening global production quotas under the Montreal Protocol are driving up R-22 prices, while the regulatory push for low-global-warming-potential gases is creating a new market for R-32, which the company began producing and selling in March 2026. - **Building blocks for life sciences** - the specialty chemicals side creates fluorine-based intermediates that make agrochemicals and pharmaceuticals more biologically active, though this segment has faced headwinds from Chinese dumping and competitive market dynamics. ## 3. Bulk Chemicals: the commodity engine that feeds the rest **This segment produces high-volume industrial chemicals like caustic soda and chloromethanes, operating as a cyclical cash generator that also provides critical, captive feedstock for the company’s downstream refrigerant and fluoropolymer operations.** - **A captive feedstock loop** - the chloroform produced here is a direct raw material for the refrigerant gas R-22, creating an internal synergy that insulates the downstream businesses from open-market price swings and supply disruptions. - **Cyclical, not strategic** - caustic soda plants run at full capacity, but pricing is range-bound due to domestic capacity additions, and the chloromethane market faces its own pricing pressure from new competitor supply, making this a volume game tied to industrial cycles. ## 4. Battery Materials: the all-in-one bet on the energy transition **Housed in subsidiary GFCL EV, this is a fully integrated, battery-agnostic materials platform - the only company in the world offering electrolyte salts, cathode materials, anode materials, and binders under one roof, explicitly built as a credible non-Chinese supplier for Western EV and energy storage markets.** - **Covering 70% of a battery cell’s cost** - the portfolio spans LiPF6 salt, LFP cathode active material, PVDF binders, electrolyte formulations, and natural graphite anode material, meaning it can supply nearly the entire bill of materials for an LFP battery cell. - **IRA-compliant by design** - the products are compliant with US Inflation Reduction Act requirements, enabled by IRA-compliant feedstock via Moroccan fluorspar, which has a free-trade agreement with the USA, giving it a clear lane into the American market. - **Validation is the gatekeeper** - after a grueling 3-4 year customer approval cycle, the LiPF6 salt has been approved by most of the major global electrolyte players, and commercial sales are scaling up, while for cathode active material, off-take agreements are in place for the entire capacity with final qualification expected by the end of Q3, after which commercial supply will commence. - **A capital-heavy buildout** - the fully integrated complex in Jolva, Gujarat, has commissioned all initial phase-one capacities, with a cumulative capex plan of INR6,000 crores by FY28, funded in part by a INR1,000 crore equity raise at a INR25,000 crore valuation and a further US$130 million from global investors. ## 5. Solar & Green Hydrogen Products: a fluoropolymer extension into new energy **This subsidiary leverages the company’s core fluoropolymer know-how to develop advanced films and membranes for solar panels and hydrogen electrolyzers, turning the existing materials platform toward the energy transition’s hardware.** - **India’s first PVDF solar film** - the company is setting up a project to make PVDF film for solar panel backsheets, integrated backward into its own PVDF manufacturing, which eliminates dependence on third-party polymer suppliers. - **Membranes for the hydrogen economy** - it is developing proton exchange membranes (PEM) for electrolyzers and fuel cells, and already supplies fluoropolymers like FKM, PTFE, and FEP into the hydrogen value chain. # Manufacturing & Operations **A single, integrated production backbone stretching from a Moroccan mine to three Gujarat chemical complexes, with captive power and deep backward integration that turns raw minerals into advanced materials under one control.** - **Three plants, one logic** - the Ranjit Nagar facility (commissioned 1989) makes specialty chemicals and refrigerants; Dahej (2007) is the largest fluoropolymer plant in India; and Jolva houses the fully integrated battery materials complex, with the Ranjit Nagar and Dahej plants certified to ISO 9001, 14001, and 45001 standards. - **The mine that secures the chain** - a wholly-owned fluorspar mine in Morocco, operated through step-down subsidiary GFL GM Fluorspar SA, provides captive access to the critical mineral that starts the entire fluorine value chain. - **Captive inputs, captive power** - the company makes its own hydrofluoric acid and lithium fluoride in-house, is backward-integrating into R-142b feedstock for its PVDF and FKM production, and runs a combined coal-and-gas captive power plant of around 90 MW at Dahej, with a 125 MW wind power asset delayed, with 20-25 MW expected to be installed by March 31, 2022. - **Green chemistry as a technology edge** - the R&D team, operating from a DST-approved research centre and collaborating with IITs and national laboratories, has successfully eliminated fluorinated surfactants from the emulsion polymerisation process, replacing them with non-fluorinated alternatives across several fluoropolymers. # Group structure and partners **GFL is the flagship chemical arm of the multi-billion-dollar INOXGFL Group, with a web of subsidiaries that ring-fence its new-energy bets and a trading network that puts warehouses in Europe, the USA, and the Middle East.** - **The parent group** - the INOXGFL Group spans chemicals and renewables, with listed siblings Inox Wind (wind turbines and turnkey EPC) and Inox Green Energy Services (India’s only listed pure-play renewable O&M company, managing roughly 13 GW of assets). - **Ring-fenced new energy** - the battery materials business sits in GFCL EV Products Ltd, which raised capital from IFC and global investors; the solar and hydrogen business is in GFCL Solar and Green Hydrogen Products Ltd; and a new subsidiary for semiconductor-grade specialty chemicals was incorporated in June 2026. - **Global trading hubs** - wholly-owned subsidiaries in Dubai, the USA (Americas LLC), Germany (GmbH), and Singapore serve as warehousing, trading, and investment hubs, putting inventory close to customers in key markets.

Documents — Gujarat Fluorochemicals Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/4wktr86vf5imazbebn42mxto.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/stn3wba36vw3usyx6yv6gezt.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/pyj67qgnoc90uaijirr5dfjo.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/hmngqyjwy6cvoub2qel8ojjq.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/s889b0of5e1qyckyg0iqs8da.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/l2eyobqmzto8b2q4t34mzzz5.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/tc9a3a2ko18vns2g2aafrmcs.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/dxwemhh01wfvdh4ygkv66zto.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/itbuvsxhxz6bzl11ggj2x2t8.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/57m4vrafhme6p9mp8uo9tat0.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/6h9gmj0ktnliksvjixdjywxt.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/7t3thzkarsngrvgcfo14euxg.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/rlyhroo7mrzixuscnea822uw.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/wp2nmquwboeptppwknlcvo33.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/wuzhpjl8n6rjzdakpefv4mbx.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/sji5x31uievjbqalynfyhq59.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/brdcv8mkk7im4pn4r15o6yt0.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/rlup228syjni3fcyo6ldi6bw.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/avd3ckh7qh7cxime19nnvtyt.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/tmpcvxxcwbzg94xjp8nz1jqh.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/nwlktlo8k3vm4yn7krchv0ra.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/n4xulrmiypreoqe382q2c43m.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/igwtyikuy9bopfa9g1p09qu2.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/4u0nusojpugny017y0fg2qx3.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/k05azp2i2cam9tiyeqlyq1kl.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/s0vpyedi2ysoh9qrdfkhzvo2.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/976mw4vyy1oalt69f7llcaey.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/oe4kmshf5e5z585wp0zgyxca.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/cihb12a41zuem3azof1q6vy4.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/ydf91wifobpuan8idasb1av8.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/wqmzyxcso2wcozd3xamhlxlk.pdf

Concall Transcript Summaries — Gujarat Fluorochemicals Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AFLUOROCHEM/transcript-notes/202606/4wktr86vf5imazbebn42mxto.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AFLUOROCHEM/transcript-notes/202603/stn3wba36vw3usyx6yv6gezt.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AFLUOROCHEM/transcript-notes/202512/pyj67qgnoc90uaijirr5dfjo.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AFLUOROCHEM/transcript-notes/202509/hmngqyjwy6cvoub2qel8ojjq.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AFLUOROCHEM/transcript-notes/202506/s889b0of5e1qyckyg0iqs8da.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AFLUOROCHEM/transcript-notes/202503/l2eyobqmzto8b2q4t34mzzz5.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AFLUOROCHEM/transcript-notes/202412/tc9a3a2ko18vns2g2aafrmcs.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AFLUOROCHEM/transcript-notes/202409/dxwemhh01wfvdh4ygkv66zto.pdf